{"id":"https://openalex.org/W2005157575","doi":"https://doi.org/10.3109/0284186x.2013.776175","title":"Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma","display_name":"Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma","publication_year":2013,"publication_date":"2013-03-20","ids":{"openalex":"https://openalex.org/W2005157575","doi":"https://doi.org/10.3109/0284186x.2013.776175","mag":"2005157575","pmid":"https://pubmed.ncbi.nlm.nih.gov/23514584"},"language":"en","primary_location":{"id":"doi:10.3109/0284186x.2013.776175","doi":"https://doi.org/10.3109/0284186x.2013.776175","is_oa":true,"landing_page_url":"https://doi.org/10.3109/0284186x.2013.776175","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.776175?download=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.776175?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033554492","display_name":"Karen\u2010Lise Garm Spindler","orcid":"https://orcid.org/0000-0001-8781-3212","observed_orcids":["https://orcid.org/0000-0001-8781-3212"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Karen-Lise G. Spindler","raw_affiliation_strings":["Department of Oncology, Vejle Hospital, Vejle, Denmark. Karen-Lise.Garm.Spindler@slb.regionsyddanmark.dk","Department of Oncology, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Vejle, Denmark. Karen-Lise.Garm.Spindler@slb.regionsyddanmark.dk","institution_ids":["https://openalex.org/I4210091196"]},{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070373312","display_name":"Morten Mau\u2010S\u00f8rensen","orcid":"https://orcid.org/0000-0003-2235-1250","observed_orcids":["https://orcid.org/0000-0003-2235-1250"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Morten M. Sorensen","raw_affiliation_strings":["Department of Oncology, Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075557171","display_name":"Niels Pallisgaard","orcid":"https://orcid.org/0000-0002-0749-0810","observed_orcids":["https://orcid.org/0000-0002-0749-0810"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Niels Pallisgaard","raw_affiliation_strings":["Department of Biochemistry, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055617960","display_name":"Rikke Fredslund Andersen","orcid":"https://orcid.org/0000-0002-5894-7745","observed_orcids":["https://orcid.org/0000-0002-5894-7745"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Rikke F. Andersen","raw_affiliation_strings":["Department of Biochemistry, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014020558","display_name":"Birgitte Mayland Havelund","orcid":"https://orcid.org/0000-0002-6566-5367","observed_orcids":["https://orcid.org/0000-0002-6566-5367"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Birgitte M. Havelund","raw_affiliation_strings":["Department of Oncology, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088764523","display_name":"John Pl\u00f8en","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"John Ploen","raw_affiliation_strings":["Department of Oncology, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077199450","display_name":"Ulrik Lassen","orcid":"https://orcid.org/0000-0002-3865-4574","observed_orcids":["https://orcid.org/0000-0002-3865-4574"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ulrik Lassen","raw_affiliation_strings":["Department of Oncology, Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048866467","display_name":"Anders Kristian Moeller Jakobsen","orcid":"https://orcid.org/0000-0003-2110-2615","observed_orcids":["https://orcid.org/0000-0003-2110-2615"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Anders K. M. Jakobsen","raw_affiliation_strings":["Department of Oncology, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5033554492"],"corresponding_institution_ids":["https://openalex.org/I4210091196"],"apc_list":null,"apc_paid":null,"fwci":2.8607,"has_fulltext":true,"cited_by_count":60,"citation_normalized_percentile":{"value":0.91134353,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"52","issue":"5","first_page":"963","last_page":"970"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.996999979019165},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemotherapy-refractory-cancer","display_name":"chemotherapy-refractory cancer","score":0.8220000267028809},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7160000205039978},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.6679999828338623},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8884252309799194},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8876380324363708},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8483035564422607},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.7595347166061401},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7441880702972412},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.636023759841919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6304136514663696},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5117661952972412},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3334309458732605},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.16901323199272156},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14701619744300842},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10253480076789856},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.08193817734718323},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3109/0284186x.2013.776175","doi":"https://doi.org/10.3109/0284186x.2013.776175","is_oa":true,"landing_page_url":"https://doi.org/10.3109/0284186x.2013.776175","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.776175?download=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},{"id":"pmid:23514584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23514584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta oncologica (Stockholm, Sweden)","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/c4d2de0e-f7b8-4952-bca6-d99c8f4b2de1","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/c4d2de0e-f7b8-4952-bca6-d99c8f4b2de1","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Spindler, K-L G, Sorensen, M M, Pallisgaard, N, Andersen, R F, Havelund, B M, Ploen, J, Lassen, U & Jakobsen, A K M 2013, 'Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer : Outcome and results of KRAS mutational analysis in plasma', Acta Oncologica, vol. 52, no. 5, pp. 963-970. https://doi.org/10.3109/0284186X.2013.776175","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/6e03aad6-72ec-410d-8a01-4b8caf7b0d24","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/6e03aad6-72ec-410d-8a01-4b8caf7b0d24","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Spindler, K-L G, S\u00f8rensen, M, Pallisgaard, N, Andersen, R, Havelund, B M, Ploen, J, Lassen, U & Jakobsen, L A 2013, 'Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer : Outcome and results of KRAS mutational analysis in plasma', Acta Oncologica, vol. 52, no. 5, pp. 963-970. https://doi.org/10.3109/0284186X.2013.776175","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3109/0284186x.2013.776175","doi":"https://doi.org/10.3109/0284186x.2013.776175","is_oa":true,"landing_page_url":"https://doi.org/10.3109/0284186x.2013.776175","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.776175?download=true","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332622","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005157575.pdf","grobid_xml":"https://content.openalex.org/works/W2005157575.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1967470942","https://openalex.org/W1971754065","https://openalex.org/W1974365898","https://openalex.org/W1985282297","https://openalex.org/W1999746552","https://openalex.org/W2022995662","https://openalex.org/W2033338515","https://openalex.org/W2044362858","https://openalex.org/W2059890247","https://openalex.org/W2065703106","https://openalex.org/W2100543432","https://openalex.org/W2112001957","https://openalex.org/W2118073504","https://openalex.org/W2133475958","https://openalex.org/W2133864098","https://openalex.org/W2134519717","https://openalex.org/W2147394591","https://openalex.org/W2149218373","https://openalex.org/W2160407991","https://openalex.org/W2171106159","https://openalex.org/W2406022066"],"related_works":["https://openalex.org/W2013276797","https://openalex.org/W2274027958","https://openalex.org/W1973045623","https://openalex.org/W2998736009","https://openalex.org/W2590871418","https://openalex.org/W2087641304","https://openalex.org/W2970137014","https://openalex.org/W2019234207","https://openalex.org/W2243357766","https://openalex.org/W2590010214"],"abstract_inverted_index":{"BACKGROUND:":[0],"Patients":[1,74,180],"with":[2,28,86,172,181,198],"chemotherapy":[3,25,218],"refractory":[4,26],"metastatic":[5],"colorectal":[6],"cancer":[7],"and":[8,68,94,129,135,155,166],"KRAS":[9,29,55,65,107,162,220,225],"mutations":[10,56],"have":[11],"no":[12],"effective":[13],"treatment":[14],"option.":[15],"The":[16,159],"present":[17],"study":[18],"evaluated":[19],"the":[20,44,59,106],"efficacy":[21,216],"of":[22,46,64,178,188,231],"temsirolimus":[23,39,77],"in":[24,110,164,196,217],"mCRC":[27],"mutations.":[30],"Furthermore,":[31],"we":[32,49],"wanted":[33],"to":[34,38,57,104,151,194],"investigate":[35,58],"if":[36],"resistance":[37],"could":[40],"be":[41],"reversed":[42],"by":[43],"addition":[45],"irinotecan.":[47],"Finally,":[48],"analyzed":[50],"pre-treatment":[51],"blood":[52],"samples":[53],"for":[54],"association":[60],"between":[61,161],"quantitative":[62],"measures":[63],"mutated":[66,108],"alleles":[67,109],"clinical":[69],"outcome.":[70,232],"MATERIAL":[71],"AND":[72],"METHODS:":[73],"received":[75],"weekly":[76,95],"25":[78],"mg":[79],"until":[80],"progression.":[81],"Thereafter":[82],"patients":[83,115,137,171,197],"were":[84,116],"treated":[85],"combination":[87,132],"therapy":[88],"comprising":[89],"biweekly":[90],"irinotecan":[91],"180":[92],"mg/m(2)":[93],"temsirolimus.":[96],"A":[97],"polymerase":[98],"chain":[99],"reaction":[100],"method":[101],"was":[102,119,146,153,168,207],"used":[103],"quantify":[105],"plasma":[111,167,224],"(pKRAS).":[112],"RESULTS:":[113],"Sixty-four":[114],"included.":[117],"Treatment":[118],"well":[120],"tolerated.":[121],"Thirty-eight":[122],"percent":[123],"achieved":[124],"stable":[125],"disease":[126],"on":[127,131,191],"monotherapy":[128,192],"63%":[130],"therapy.":[133],"Four":[134],"eight":[136],"had":[138,175,184],"a":[139,185,208,228],"minimal":[140],"response,":[141],"respectively.":[142,158],"Median":[143,149],"overall":[144],"survival":[145,202],"160":[147],"days.":[148],"time":[150],"progression":[152,190],"45":[154],"84":[156],"days,":[157],"concordance":[160],"status":[163],"tumor":[165,173],"82%.":[169],"All":[170],"reduction":[174],"low":[176],"levels":[177],"pKRAS.":[179],"high":[182],"pKRAS":[183,206],"77%":[186],"risk":[187],"early":[189],"compared":[193],"43%":[195],"lower":[199],"levels.":[200],"Multivariate":[201],"analysis":[203],"confirmed":[204],"that":[205],"strong":[209,229],"prognostic":[210],"factor.":[211],"CONCLUSION:":[212],"Temsirolimus":[213],"has":[214],"limited":[215],"resistant":[219],"mutant":[221],"disease,":[222],"but":[223],"quantification":[226],"is":[227],"predictor":[230]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}